Curasight A/S Logo

Curasight A/S

Developing uPAR theranostics to precisely diagnose and treat cancers like brain and prostate.

CURAS | SPGR

Overview

Corporate Details

ISIN(s):
DK0061295797 (+3 more)
LEI:
984500C9E3ADR98F1070
Country:
Denmark
Address:
Ole Maaløes Vej 3, 2200 København N
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Curasight A/S is a clinical-stage biotechnology company developing a more gentle and efficient approach to cancer care through its proprietary uPAR Theranostics platform. This technology targets the urokinase-type plasminogen activator receptor (uPAR), a biomarker expressed in numerous cancers. The platform integrates precise diagnostics using the uTRACE® imaging agent with targeted radionuclide therapy delivered by the uTREAT® agent. This integrated 'theranostics' approach aims to improve treatment outcomes by accurately identifying and treating cancer while minimizing radiation damage to healthy tissue. The company's clinical development focuses on several indications, including brain and prostate cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Curasight A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Curasight A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.